• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑转移肺癌患者全脑放疗与医疗水平及生存的关系评估

Evaluation of Whole Brain Radiotherapy among Lung Cancer Patients with Brain Metastases in Relation to Health Care Level and Survival.

作者信息

Frisk Gabriella, Helde Frankling Maria, Warnqvist Anna, Björkhem-Bergman Linda, Hedman Mattias

机构信息

Department of Neurobiology, Care Sciences and Society (NVS), Division of Clinical Geriatrics, Karolinska Institutet, 141 83 Huddinge, Sweden.

ASIH Stockholm Södra, Palliative Home Care and Specialized Palliative Ward, 125 59 Älvsjö, Sweden.

出版信息

Life (Basel). 2022 Apr 1;12(4):525. doi: 10.3390/life12040525.

DOI:10.3390/life12040525
PMID:35455016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9031780/
Abstract

Whole-brain radiotherapy (WBRT) as a treatment for brain metastases has been questioned over the last years. This study aimed to evaluate health care levels and survival after WBRT in a cohort of lung cancer patients with brain metastases receiving WBRT in Stockholm, Sweden, from 2008 to 2019 ( = 384). If the patients were able to come home again was estimated using logistic regression and odds ratios (OR) and survival by using Cox regression. The median age in the cohort was 65.6 years, the median survival following WBRT was 2.4 months (interquartile range (IQR) 1.2-6.2 months), and 84 (22%) patients were not able to come home after treatment. Significantly more males could come home again after WBRT compared to women (OR = 0.37, 95%CI 0.20-0.68). Patients with performance status scores WHO 3-4 had a median survival of 1.0 months, hazard ratio (HR) = 4.69 (95%CI 3.31-6.64) versus WHO score 0-1. Patients admitted to a palliative ward before WBRT had a median survival of 0.85 months, HR = 2.26 (95%CI 1.53-3.34) versus being at home. In conclusion, patients treated with WBRT had a short median survival and 20% could not be discharged from the hospital following treatment. Significantly more women did not come home again.

摘要

在过去几年中,全脑放疗(WBRT)作为脑转移瘤的一种治疗方法一直备受质疑。本研究旨在评估2008年至2019年在瑞典斯德哥尔摩接受WBRT的一组肺癌脑转移患者接受WBRT后的医疗保健水平和生存率(n = 384)。使用逻辑回归和比值比(OR)估计患者是否能够再次回家,并使用Cox回归分析生存率。该队列的中位年龄为65.6岁,WBRT后的中位生存期为2.4个月(四分位间距(IQR)为1.2 - 6.2个月),84名(22%)患者在治疗后无法回家。与女性相比,接受WBRT后能够再次回家的男性明显更多(OR = 0.37,95%CI 0.20 - 0.68)。世界卫生组织(WHO)功能状态评分为3 - 4分的患者中位生存期为1.0个月,风险比(HR)= 4.69(95%CI 3.31 - 6.64),而WHO评分为0 - 1分的患者为对照。在WBRT前入住姑息病房的患者中位生存期为0.85个月,HR = 2.26(95%CI 1.53 - 3.34),而在家中的患者为对照。总之,接受WBRT治疗的患者中位生存期较短,20%的患者在治疗后无法出院。女性不能再次回家的比例明显更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c800/9031780/d9a91dce3501/life-12-00525-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c800/9031780/6e4b7489ce65/life-12-00525-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c800/9031780/e9c61ad59178/life-12-00525-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c800/9031780/d9a91dce3501/life-12-00525-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c800/9031780/6e4b7489ce65/life-12-00525-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c800/9031780/e9c61ad59178/life-12-00525-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c800/9031780/d9a91dce3501/life-12-00525-g003.jpg

相似文献

1
Evaluation of Whole Brain Radiotherapy among Lung Cancer Patients with Brain Metastases in Relation to Health Care Level and Survival.脑转移肺癌患者全脑放疗与医疗水平及生存的关系评估
Life (Basel). 2022 Apr 1;12(4):525. doi: 10.3390/life12040525.
2
Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy.脑转移乳腺癌患者接受全脑放疗后的生存和护理水平。
Breast Cancer Res Treat. 2017 Dec;166(3):887-896. doi: 10.1007/s10549-017-4466-3. Epub 2017 Aug 22.
3
Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study.小细胞肺癌脑转移一线立体定向放疗与全脑放疗的评价:FIRE-SCLC 队列研究。
JAMA Oncol. 2020 Jul 1;6(7):1028-1037. doi: 10.1001/jamaoncol.2020.1271.
4
Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.脑转移瘤切除术后立体定向腔隙照射或全脑放疗——结果、预后因素及复发模式
Front Oncol. 2020 May 8;10:693. doi: 10.3389/fonc.2020.00693. eCollection 2020.
5
Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.接受全脑放疗的小细胞肺癌脑转移患者的治疗结果及预后因素
J Neurooncol. 2017 Aug;134(1):205-212. doi: 10.1007/s11060-017-2510-0. Epub 2017 May 30.
6
A matched-pair analysis comparing stereotactic radiosurgery with whole-brain radiotherapy for patients with multiple brain metastases.一项配对分析比较了立体定向放射外科与全脑放疗治疗多发脑转移瘤患者的效果。
J Neurooncol. 2020 May;147(3):607-618. doi: 10.1007/s11060-020-03447-2. Epub 2020 Apr 1.
7
Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.全脑放疗用于治疗新诊断的多发脑转移瘤。
Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD003869. doi: 10.1002/14651858.CD003869.pub3.
8
Added survival benefit of whole brain radiotherapy in brain metastatic non-small cell lung cancer: Development and external validation of an individual prediction model.全脑放疗对脑转移非小细胞肺癌的额外生存获益:个体预测模型的开发与外部验证
Front Oncol. 2022 Nov 29;12:911835. doi: 10.3389/fonc.2022.911835. eCollection 2022.
9
Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014.在 2000 年至 2014 年间,荷兰有 6325 例肺癌和乳腺癌脑转移患者接受了全脑放疗,但他们的生存状况较差。
Acta Oncol. 2018 May;57(5):637-643. doi: 10.1080/0284186X.2017.1418534. Epub 2017 Dec 23.
10
Whole brain radiotherapy after stereotactic radiosurgery or surgical resection among patients with one to three brain metastases and favorable prognoses: a secondary analysis of EORTC 22952-26001.单发至三发脑转移且预后良好的患者立体定向放射外科或手术切除后行全脑放疗:EORTC 22952-26001 研究的二次分析。
Ann Oncol. 2017 Oct 1;28(10):2588-2594. doi: 10.1093/annonc/mdx332.

引用本文的文献

1
Overall Survival after Radiotherapy for Brain Metastases According to ECOG Status-A Prospective Study of 294 NSCLC Patients.根据东部肿瘤协作组(ECOG)状态对脑转移瘤进行放疗后的总生存期——294例非小细胞肺癌患者的前瞻性研究
Cancers (Basel). 2024 Apr 12;16(8):1486. doi: 10.3390/cancers16081486.

本文引用的文献

1
EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours.欧洲神经肿瘤学会(EANO)与欧洲肿瘤内科学会(ESMO)实体瘤脑转移患者诊断、治疗及随访临床实践指南
Ann Oncol. 2021 Nov;32(11):1332-1347. doi: 10.1016/j.annonc.2021.07.016. Epub 2021 Aug 6.
2
Health care utilization at end of life among patients with lung or pancreatic cancer. Comparison between two Swedish cohorts.终末期肺癌和胰腺癌患者的医疗保健利用。两个瑞典队列的比较。
PLoS One. 2021 Jul 16;16(7):e0254673. doi: 10.1371/journal.pone.0254673. eCollection 2021.
3
Overall survival after initial radiotherapy for brain metastases; a population based study of 2140 patients with non-small cell lung cancer.
非小细胞肺癌脑转移患者初始放疗后总生存:2140 例患者的基于人群研究。
Acta Oncol. 2021 Aug;60(8):1054-1060. doi: 10.1080/0284186X.2021.1924399. Epub 2021 May 25.
4
Chronic obstructive pulmonary disease and lung cancer: access to palliative care, emergency room visits and hospital deaths.慢性阻塞性肺疾病和肺癌:姑息治疗、急诊就诊和医院死亡的途径。
BMC Pulm Med. 2021 May 19;21(1):170. doi: 10.1186/s12890-021-01533-3.
5
Epidemiology of brain metastases and leptomeningeal disease.脑转移瘤和软脑膜疾病的流行病学。
Neuro Oncol. 2021 Sep 1;23(9):1447-1456. doi: 10.1093/neuonc/noab101.
6
Management of multiple brain metastases: a patterns of care survey within the German Society for Radiation Oncology.多脑转移瘤的治疗管理:德国放射肿瘤学会的一项治疗模式调查。
J Neurooncol. 2021 Apr;152(2):395-404. doi: 10.1007/s11060-021-03714-w. Epub 2021 Feb 23.
7
Brain metastases in metastatic cancer: a review of recent advances in systemic therapies.转移性癌症中的脑转移瘤:系统治疗最新进展综述。
Expert Rev Anticancer Ther. 2021 Mar;21(3):325-339. doi: 10.1080/14737140.2021.1851200. Epub 2020 Nov 30.
8
Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine.非小细胞肺癌脑转移的放射治疗作用——临床常规中的决策标准。
Radiother Oncol. 2021 Jan;154:269-273. doi: 10.1016/j.radonc.2020.10.043. Epub 2020 Nov 11.
9
Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient.脑转移瘤患者的生存:诊断特异性分级预后评估更新的总结报告和资格系数的定义。
J Clin Oncol. 2020 Nov 10;38(32):3773-3784. doi: 10.1200/JCO.20.01255. Epub 2020 Sep 15.
10
Redefining Palliative Care-A New Consensus-Based Definition.重新定义姑息治疗——基于共识的新定义
J Pain Symptom Manage. 2020 Oct;60(4):754-764. doi: 10.1016/j.jpainsymman.2020.04.027. Epub 2020 May 6.